<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Extragenital lichen sclerosus: Clinical features and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Extragenital lichen sclerosus: Clinical features and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Extragenital lichen sclerosus: Clinical features and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Heidi Jacobe, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeffrey Callen, MD, FACP, FAAD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Abena O Ofori, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 11, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1945208">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lichen sclerosus (also known as lichen sclerosus et atrophicus) is a chronic, inflammatory skin disorder characterized by atrophic plaques on the skin or mucous membranes. Genital lichen sclerosus, particularly vulvar lichen sclerosus, is considered the most frequent presentation. (See
         <a class="medical medical_review" href="/z/d/html/5558.html" rel="external">
          "Vulvar lichen sclerosus: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         Extragenital lichen sclerosus refers to lichen sclerosus in sites other than the anogenital area. Extragenital involvement typically presents as porcelain-white, hypopigmented, or hyperpigmented, atrophic plaques  (
         <a class="graphic graphic_picture graphicRef74154 graphicRef51592 graphicRef79867 graphicRef60332 graphicRef59300" href="/z/d/graphic/74154.html" rel="external">
          picture 1A-E
         </a>
         ) and may accompany genital lichen sclerosus, occur alone, or overlie lesions of morphea (localized scleroderma). (See
         <a class="medical medical_review" href="/z/d/html/5558.html" rel="external">
          "Vulvar lichen sclerosus: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13776.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults"
         </a>
         .)
        </p>
        <p>
         The clinical features and diagnosis of extragenital lichen sclerosus will be reviewed here. The management of extragenital lichen sclerosus and the diagnosis and management of genital lichen sclerosus are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/140876.html" rel="external">
          "Extragenital lichen sclerosus: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5558.html" rel="external">
          "Vulvar lichen sclerosus: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6876.html" rel="external">
          "Balanitis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1945215">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The true prevalence of extragenital lichen sclerosus is unknown, but the disorder appears to occur less frequently than genital lichen sclerosus [
         <a href="#rid1">
          1-3
         </a>
         ]. Extragenital lichen sclerosus often occurs in association with genital lichen sclerosus. (See
         <a class="local">
          'Concomitant genital involvement'
         </a>
         below.)
        </p>
        <p>
         Similar to genital lichen sclerosus, extragenital disease appears to be more common in females than males. In a retrospective review, 17 out of 20 patients with histopathologic findings consistent with extragenital lichen sclerosus were female [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1945222">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenesis of lichen sclerosus is poorly studied. Most information on this subject has been derived from studies on genital disease.
        </p>
        <p>
         Proposed etiologic factors for lichen sclerosus include immune dysfunction, genetic predisposition, infectious agents, and trauma [
         <a href="#rid5">
          5-14
         </a>
         ]. In addition, the development of extragenital lichen sclerosus in patients with metastatic melanoma treated with
         <a class="drug drug_general" data-topicid="16084" href="/z/d/drug information/16084.html" rel="external">
          ipilimumab
         </a>
         in combination with
         <a class="drug drug_general" data-topicid="98764" href="/z/d/drug information/98764.html" rel="external">
          nivolumab
         </a>
         or other checkpoint inhibitors is described in case reports [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5558.html" rel="external">
          "Vulvar lichen sclerosus: Clinical manifestations and diagnosis", section on 'Etiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1945229">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Extragenital lichen sclerosus can occur in any location on the skin and infrequently appears in the oral cavity. Conjunctival lesions do not occur. Concomitant genital lichen sclerosus or morphea lesions may be present [
         <a href="#rid16">
          16
         </a>
         ]. (See
         <a class="local">
          'Concomitant genital involvement'
         </a>
         below and
         <a class="local">
          'Concomitant morphea'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H704587">
         <span class="h2">
          Cutaneous lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cutaneous findings evolve over time, have a variable distribution, and may present with associated symptoms:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Morphology
         </strong>
         – Early, active skin lesions of extragenital lichen sclerosus often appear as flat-topped and slightly scaly, hypopigmented, white, or mildly erythematous, polygonal papules that may coalesce to form larger plaques with peripheral erythema  (
         <a class="graphic graphic_picture graphicRef58815 graphicRef70580 graphicRef70084" href="/z/d/graphic/58815.html" rel="external">
          picture 2A-C
         </a>
         ). Over time, as activity subsides, lesions may develop a porcelain-white color; variable degrees of palpable sclerosis; and a cigarette paper-like, wrinkled appearance that correlates with epidermal and superficial, dermal atrophy  (
         <a class="graphic graphic_picture graphicRef74154 graphicRef79867 graphicRef60332 graphicRef107703" href="/z/d/graphic/74154.html" rel="external">
          picture 1A, 1C-D, 1F
         </a>
         ). In individuals with highly pigmented skin, established lesions may demonstrate hyperpigmentation and hypopigmentation rather than a porcelain-white color  (
         <a class="graphic graphic_picture graphicRef51592 graphicRef59300" href="/z/d/graphic/51592.html" rel="external">
          picture 1B, 1E
         </a>
         ) [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Telangiectasias; follicular, keratotic plugs; and hemorrhagic or nonhemorrhagic bullae may also be present  (
         <a class="graphic graphic_picture graphicRef79659" href="/z/d/graphic/79659.html" rel="external">
          picture 3
         </a>
         ) [
         <a href="#rid18">
          18,19
         </a>
         ]. Examples of reported dermoscopic findings include structureless, white to yellow areas; chrysalis-like structures; linear, irregular vessels; perifollicular scaling; keratotic plugs; and rosettes [
         <a href="#rid20">
          20-22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Distribution
         </strong>
         – Extragenital lesions are commonly found on the back, shoulder, neck, wrist, thigh, and inframammary areas [
         <a href="#rid23">
          23,24
         </a>
         ]. In our experience, the lesions are often symmetrically distributed and located in areas of chronic friction. Cutaneous lesions following the lines of Blaschko  (
         <a class="graphic graphic_figure graphicRef57219" href="/z/d/graphic/57219.html" rel="external">
          figure 1
         </a>
         ) have also been reported [
         <a href="#rid25">
          25,26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Symptoms and complications
         </strong>
         – Extragenital lichen sclerosus ranges from an asymptomatic condition involving limited body sites to widely distributed lesions that can be severely disabling. Patients experience pruritus, a sensation of burning skin, and/or painful fissuring. Such symptoms may be more frequent when lesions are located in areas subject to friction or tension, such as the inframammary folds, antecubital fossae, axillae, waist, inguinal creases, and popliteal fossae. Bullae may develop, often with hemorrhage resulting in erosions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Extragenital lichen sclerosus can negatively impact quality of life by limiting clothing choices, inhibiting participation in occupational and leisure activities, and contributing to concern about the appearance and texture of affected skin. In addition, trauma to unaffected skin, such as injury from tight clothing, injections, radiation therapy, herpes zoster, or other factors, may precipitate new lesions (Koebner phenomenon)  (
         <a class="graphic graphic_picture graphicRef72972" href="/z/d/graphic/72972.html" rel="external">
          picture 4
         </a>
         ) [
         <a href="#rid13">
          13,14,27-29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In the author's experience, the residual atrophic cutaneous changes of lichen sclerosus are prone to xerosis as well as asteatotic and irritant dermatitis. Patients often require active management of these complications.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H704594">
         <span class="h2">
          Oral lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral lichen sclerosus is rare and involves the lips, gingiva, palate, tongue, or buccal mucosa in children and adults [
         <a href="#rid30">
          30-33
         </a>
         ]. Lesions often appear as irregular, white or hypopigmented plaques and may be atrophic, causing gingival recession. Most patients are asymptomatic but may experience pruritus, burning, or tightness in affected areas [
         <a href="#rid30">
          30,31,34
         </a>
         ]. Oral lesions may present independently or in association with lichen sclerosus in other sites [
         <a href="#rid35">
          35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/140876.html" rel="external">
          "Extragenital lichen sclerosus: Management", section on 'Oral disease'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4100651584">
         <span class="h2">
          Concomitant genital involvement
         </span>
         <span class="headingEndMark">
          —
         </span>
         Coexistence with genital involvement may be common, warranting evaluation for genital involvement in all patients [
         <a href="#rid1">
          1-3
         </a>
         ]. In one series of 355 female adults and children with genital and/or extragenital lichen sclerosus, approximately 16 percent had both extragenital and genital lesions, and only 3 percent had isolated extragenital lesions [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H238985308">
         <span class="h2">
          Concomitant morphea
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical findings consistent with genital or extragenital lichen sclerosus may occur in patients with morphea  (
         <a class="graphic graphic_picture graphicRef82529 graphicRef53986" href="/z/d/graphic/82529.html" rel="external">
          picture 5A-B
         </a>
         ) [
         <a href="#rid36">
          36-39
         </a>
         ]. It is unclear whether the appearance of lesions consistent with lichen sclerosus represents the simultaneous occurrence of two separate disorders or the development of clinical findings that resemble lichen sclerosus in lesions of morphea. (See
         <a class="medical medical_review" href="/z/d/html/13776.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
         The frequency of extragenital lichen sclerosus in patients with morphea was evaluated in a retrospective study of 381 adults and 91 children with morphea [
         <a href="#rid37">
          37
         </a>
         ]. Extragenital lichen sclerosus was detected in 19 patients (4 percent). Additional studies are necessary to confirm the frequency of extragenital lichen sclerosus in this population. (See
         <a class="medical medical_review" href="/z/d/html/13776.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults", section on 'Lichen sclerosus'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13776.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults", section on 'Generalized morphea'
         </a>
         .)
        </p>
        <p>
         The potential for coexisting morphea and genital lichen sclerosus supports performing genital examinations in patients with morphea. In the author's practice, most patients with morphea and genital lichen sclerosus have been postmenopausal females in whom features of extragenital lichen sclerosus accompany morphea. (See
         <a class="medical medical_review" href="/z/d/html/13776.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults", section on 'History and physical examination'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1908255357">
         <span class="h1">
          HISTOPATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The characteristic pathologic features of lichen sclerosus include  (
         <a class="graphic graphic_picture graphicRef58841" href="/z/d/graphic/58841.html" rel="external">
          picture 6
         </a>
         ) [
         <a href="#rid4">
          4
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epidermal hyperkeratosis with follicular plugging
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epidermal atrophy with flattening of rete ridges
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vacuolization of the basal layer of the epidermis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Marked edema in the superficial dermis (early lesions)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Homogenized collagen in the upper dermis (established lesions)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lymphohistiocytic infiltrate underlying the zone of homogenized collagen
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H704608">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of extragenital lichen sclerosus can often be made based on the clinical appearance, particularly in patients with porcelain-white, atrophic lesions. (See
         <a class="local">
          'Cutaneous lesions'
         </a>
         above.)
        </p>
        <p>
         When the diagnosis is uncertain, such as when features suggestive of other disorders are also present, a punch biopsy is useful for confirming the diagnosis. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">
          "Skin biopsy techniques", section on 'Punch biopsy'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Additional clinical assessment
         </strong>
         – Patients with skin findings consistent with extragenital lichen sclerosus should undergo a complete examination of the skin, oral cavity, and external anogenital skin. This allows for the assessment of the extent of skin disease and the identification of patients with associated oral or genital lichen sclerosus or morphea. The recognition of genital lichen sclerosus is particularly important because of its association with an increased risk for squamous cell carcinoma. Patients may be unaware of genital lesions or hesitant to mention them. (See
         <a class="medical medical_review" href="/z/d/html/5558.html" rel="external">
          "Vulvar lichen sclerosus: Clinical manifestations and diagnosis", section on 'Association with malignancy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Recognition of patients with a history of immune checkpoint inhibitor therapy may also be relevant. Extragenital lichen sclerosus has been reported in patients treated with immune checkpoint inhibitors [
         <a href="#rid15">
          15
         </a>
         ]. However, an association has not been confirmed. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role of histopathology
         </strong>
         – The identification of characteristic histopathologic findings in biopsies of lesions suspicious for extragenital lichen sclerosus is almost always indicative of the diagnosis  (
         <a class="graphic graphic_picture graphicRef58841" href="/z/d/graphic/58841.html" rel="external">
          picture 6
         </a>
         ). Although similar histopathologic findings occur in the lichen sclerosus-like variant of chronic graft-versus-host disease, the clinical history facilitates the differentiation of these disorders. (See
         <a class="local">
          'Histopathology'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/13760.html" rel="external">
          "Cutaneous manifestations of graft-versus-host disease (GVHD)", section on 'Diagnosis'
         </a>
         and
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H704623">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of disorders may present with clinical features that resemble extragenital lichen sclerosus. Examples include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vitiligo
         </strong>
         – Vitiligo is characterized by the presence of well-demarcated, depigmented patches on the skin  (
         <a class="graphic graphic_picture graphicRef74712 graphicRef63623" href="/z/d/graphic/74712.html" rel="external">
          picture 7A-B
         </a>
         ). In contrast to extragenital lichen sclerosus, skin texture is normal, without signs of atrophy or sclerosis. (See
         <a class="medical medical_review" href="/z/d/html/105109.html" rel="external">
          "Vitiligo: Pathogenesis, clinical features, and diagnosis", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lichen planus
         </strong>
         – Extragenital lichen sclerosus may present as violaceous, polygonal papules on the wrists or ankles that closely resemble lichen planus  (
         <a class="graphic graphic_picture graphicRef76383 graphicRef63590" href="/z/d/graphic/76383.html" rel="external">
          picture 8A-B
         </a>
         ) [
         <a href="#rid40">
          40,41
         </a>
         ]. Unlike extragenital lichen sclerosus, lichen planus is often pruritic. A skin biopsy can be used to distinguish between these disorders. (See
         <a class="medical medical_review" href="/z/d/html/5662.html" rel="external">
          "Lichen planus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tinea versicolor
         </strong>
         – Tinea versicolor presents with hypopigmented macules and patches primarily located on the trunk and proximal upper extremities  (
         <a class="graphic graphic_picture graphicRef100021 graphicRef72396" href="/z/d/graphic/100021.html" rel="external">
          picture 9A-B
         </a>
         ). Fine scale is often evident, and a potassium hydroxide preparation will reveal the presence of fungal elements. Signs of cutaneous atrophy and sclerosis are absent. (See
         <a class="medical medical_review" href="/z/d/html/4039.html" rel="external">
          "Tinea versicolor (pityriasis versicolor)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">
          "Office-based dermatologic diagnostic procedures", section on 'Potassium hydroxide preparation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anetoderma
         </strong>
         – In anetoderma, loss of elastin in the dermis contributes to reduced skin elasticity and the appearance of circumscribed, 1 to 3 cm areas of depressed, flaccid, wrinkled, or bulging skin  (
         <a class="graphic graphic_picture graphicRef67581" href="/z/d/graphic/67581.html" rel="external">
          picture 10
         </a>
         ). Anetoderma may occur as a primary disorder or as a result of a preceding, inflammatory process or other skin abnormality. The neck, trunk, and upper extremities are most frequently affected. (See
         <a class="medical medical_review" href="/z/d/html/110076.html" rel="external">
          "Anetoderma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cutaneous T cell lymphoma
         </strong>
         – Like extragenital lichen sclerosus, lesions of patch-stage mycosis fungoides may present with epidermal atrophy manifesting as fine, cigarette paper-like wrinkling  (
         <a class="graphic graphic_picture graphicRef60650 graphicRef63888" href="/z/d/graphic/60650.html" rel="external">
          picture 11A-B
         </a>
         ). Lesions of mycosis fungoides are often erythematous, resembling an eczematous dermatitis. Hypopigmented mycosis fungoides presents with hypopigmented patches  (
         <a class="graphic graphic_picture graphicRef106609 graphicRef71926" href="/z/d/graphic/106609.html" rel="external">
          picture 12A-B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/1674.html" rel="external">
          "Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides", section on 'Skin lesions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chronic graft-versus-host disease
         </strong>
         – Patients who have received hematopoietic cell transplants may develop lesions that closely resemble extragenital lichen sclerosus as a manifestation of chronic graft-versus-host disease  (
         <a class="graphic graphic_picture graphicRef119264" href="/z/d/graphic/119264.html" rel="external">
          picture 13
         </a>
         ). Knowledge of the patient's transplant history is useful for diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/13760.html" rel="external">
          "Cutaneous manifestations of graft-versus-host disease (GVHD)", section on 'Sclerotic manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Morphea
         </strong>
         – Skin lesions that resemble the classic, atrophic, white patches of extragenital lichen sclerosus may develop in individuals with morphea, an idiopathic, inflammatory disorder that causes sclerotic changes in the skin. The relationship between morphea and lichen sclerosus remains unclear. (See
         <a class="local">
          'Concomitant morphea'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/13776.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2351283471">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Extragenital lichen sclerosus is an uncommon disorder that may involve the skin or oral cavity. The disorder occurs more frequently in females than in males, and the occurrence in children is rare. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cutaneous lesions
         </strong>
         – Early, active skin lesions of extragenital lichen sclerosus often present as flat-topped, polygonal papules that may coalesce into large plaques  (
         <a class="graphic graphic_picture graphicRef58815 graphicRef70580 graphicRef70084" href="/z/d/graphic/58815.html" rel="external">
          picture 2A-C
         </a>
         ). Inactive lesions can develop a porcelain-white color, a finely wrinkled surface, and variable degrees of sclerosis  (
         <a class="graphic graphic_picture graphicRef74154 graphicRef79867 graphicRef60332" href="/z/d/graphic/74154.html" rel="external">
          picture 1A, 1C-D
         </a>
         ). In individuals with highly pigmented skin, lesions may be hyperpigmented or hypopigmented  (
         <a class="graphic graphic_picture graphicRef51592 graphicRef59300" href="/z/d/graphic/51592.html" rel="external">
          picture 1B, 1E
         </a>
         ). (See
         <a class="local">
          'Cutaneous lesions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Oral lesions
         </strong>
         – Oral lichen sclerosus presents as irregular, white or hypopigmented plaques on the lips or in the oral cavity. (See
         <a class="local">
          'Cutaneous lesions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – A variety of other skin disorders share clinical features with extragenital lichen sclerosus. When the diagnosis is uncertain based upon clinical examination, a skin biopsy should be performed. (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="local">
          'Differential diagnosis'
         </a>
         above and
         <a class="local">
          'Histopathology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Assessment for concomitant disorders
         </strong>
         – Extragenital lichen sclerosus can occur in association with genital lichen sclerosus or morphea. A complete examination of the skin, oral cavity, and external anogenital skin should be performed to identify patients with these disorders. (See
         <a class="local">
          'Concomitant genital involvement'
         </a>
         above and
         <a class="local">
          'Concomitant morphea'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol 1995; 32:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity--a study of 350 women. Br J Dermatol 1988; 118:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971; 57:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carlson JA, Lamb P, Malfetano J, et al. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 1998; 11:844.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sander CS, Ali I, Dean D, et al. Oxidative stress is implicated in the pathogenesis of lichen sclerosus. Br J Dermatol 2004; 151:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 1995; 33:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weide B, Walz T, Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol 2000; 142:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144:1432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan I, Oyama N, Neill SM, et al. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin Exp Dermatol 2004; 29:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oyama N, Chan I, Neill SM, et al. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest 2004; 113:1550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kowalewski C, Kozłowska A, Chan I, et al. Three-dimensional imaging reveals major changes in skin microvasculature in lipoid proteinosis and lichen sclerosus. J Dermatol Sci 2005; 38:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderton RL, Abele DC. Lichen sclerosus et atrophicus in a vaccination site. Arch Dermatol 1976; 112:1787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yates VM, King CM, Dave VK. Lichen sclerosus et atrophicus following radiation therapy. Arch Dermatol 1985; 121:1044.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Truong K, Jones-Caballero M, Chou S, et al. Lichen sclerosus and immune checkpoint inhibitors: A case and review of the literature. Australas J Dermatol 2023; 64:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prasad S, Black SM, Zhu JL, et al. Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort. J Am Acad Dermatol 2021; 85:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farris DR, Hardy D, Kagen MH, et al. Extragenital pigmented lichen sclerosus. J Eur Acad Dermatol Venereol 2000; 14:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballester I, Bañuls J, Pérez-Crespo M, Lucas A. Extragenital bullous lichen sclerosus atrophicus. Dermatol Online J 2009; 15:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garrido-Ríos AA, Alvarez-Garrido H, Sanz-Muñoz C, et al. Dermoscopy of extragenital lichen sclerosus. Arch Dermatol 2009; 145:1468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahajan SA, Dave JS. Dermoscopic Evaluation of Extragenital Lichen Sclerosus et Atrophicus. Dermatol Pract Concept 2022; 12:e2022125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Su M, Liu H, Ran Y. Successfully treated extragenital lichen sclerosus in a 2-year-old boy by baricitinib assessed by dermoscopy: A case report. Dermatol Ther 2022; 35:e15712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lacarrubba F, Pellacani G, Verzì AE, et al. Extragenital lichen sclerosus: clinical, dermoscopic, confocal microscopy and histologic correlations. J Am Acad Dermatol 2015; 72:S50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353:1777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neill SM, Lewis FM, Tatnall FM, et al. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163:672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Libow LF, Coots NV. Lichen sclerosus following the lines of Blaschko. J Am Acad Dermatol 1998; 38:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi SW, Yang JE, Park HJ, Kim CW. A case of extragenital lichen sclerosus following Blaschko's lines. J Am Acad Dermatol 2000; 43:903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forschner A, Metzler G, Rassner G, Fierlbeck G. Morphea with features of lichen sclerosus et atrophicus at the site of a herpes zoster scar: another case of an isotopic response. Int J Dermatol 2005; 44:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noakes RR, Spelman L. Köbnerization in a woman with generalized lichen sclerosus. Australas J Dermatol 2004; 45:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nemer KM, Anadkat MJ. Postirradiation Lichen Sclerosus et Atrophicus. JAMA Dermatol 2017; 153:1067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Attili VR, Attili SK. Lichen sclerosus of lips: a clinical and histopathologic study of 27 cases. Int J Dermatol 2010; 49:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azevedo RS, Romañach MJ, de Almeida OP, et al. Lichen sclerosus of the oral mucosa: clinicopathological features of six cases. Int J Oral Maxillofac Surg 2009; 38:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelly SC, Helm KF, Zaenglein AL. Lichen sclerosus of the lip. Pediatr Dermatol 2006; 23:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen T, Worsaae N, Melgaard B. Oral lichen sclerosus et atrophicus: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94:702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim CY, Kim JG, Oh CW. Treatment of oral lichen sclerosus with 1% pimecrolimus cream. Ann Dermatol 2010; 22:326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wakamatsu J, Yamamoto T, Uchida H, Tsuboi R. Lichen sclerosus et atrophicus of the lip: successful treatment with topical tacrolimus. J Eur Acad Dermatol Venereol 2008; 22:760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lutz V, Francès C, Bessis D, et al. High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea. Arch Dermatol 2012; 148:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kreuter A, Wischnewski J, Terras S, et al. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. J Am Acad Dermatol 2012; 67:1157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uitto J, Santa Cruz DJ, Bauer EA, Eisen AZ. Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol 1980; 3:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tremaine R, Adam JE, Orizaga M. Morphea coexisting with lichen sclerosus et atrophicus. Int J Dermatol 1990; 29:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vázquez MG, Navarra R, Martin-Urda MT, et al. Lichen Sclerosus et Atrophicus with Cutaneous Distribution Simulating Lichen Planus. Case Rep Dermatol 2010; 2:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corbalán-Vélez R, Pérez-Ferriols A. Lichen sclerosus et atrophicus affecting the wrists and left ankle and clinically simulating lichen planus. Cutis 2001; 67:417.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15838 Version 16.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7868709" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3342175" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Lichen sclerosus et atrophicus and autoimmunity--a study of 350 women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5570266" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Lichen sclerosus et atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9758364" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15377350" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Oxidative stress is implicated in the pathogenesis of lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7673495" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10792212" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Is morphoea caused by Borrelia burgdorferi? A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19015417" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15347336" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12867112" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Autoantibodies to extracellular matrix protein 1 in lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15173881" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15927815" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Three-dimensional imaging reveals major changes in skin microvasculature in lipoid proteinosis and lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1008571" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Lichen sclerosus et atrophicus in a vaccination site.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4026344" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Lichen sclerosus et atrophicus following radiation therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36310527" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Lichen sclerosus and immune checkpoint inhibitors: A case and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33249064" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11204533" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Extragenital pigmented lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19281711" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Extragenital bullous lichen sclerosus atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20026867" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Dermoscopy of extragenital lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36159134" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Dermoscopic Evaluation of Extragenital Lichen Sclerosus et Atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35818756" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Successfully treated extragenital lichen sclerosus in a 2-year-old boy by baricitinib assessed by dermoscopy: A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25500042" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Extragenital lichen sclerosus: clinical, dermoscopic, confocal microscopy and histologic correlations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10348006" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20854400" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9591796" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Lichen sclerosus following the lines of Blaschko.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11044817" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : A case of extragenital lichen sclerosus following Blaschko's lines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15941448" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Morphea with features of lichen sclerosus et atrophicus at the site of a herpes zoster scar: another case of an isotopic response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15068467" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Köbnerization in a woman with generalized lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28538963" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Postirradiation Lichen Sclerosus et Atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20534086" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Lichen sclerosus of lips: a clinical and histopathologic study of 27 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19395238" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Lichen sclerosus of the oral mucosa: clinicopathological features of six cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17014652" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Lichen sclerosus of the lip.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12464894" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Oral lichen sclerosus et atrophicus: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20711272" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Treatment of oral lichen sclerosus with 1% pimecrolimus cream.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18031502" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Lichen sclerosus et atrophicus of the lip: successful treatment with topical tacrolimus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22004877" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22533994" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7451694" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2228375" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Morphea coexisting with lichen sclerosus et atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21173929" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Lichen Sclerosus et Atrophicus with Cutaneous Distribution Simulating Lichen Planus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11381860" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Lichen sclerosus et atrophicus affecting the wrists and left ankle and clinically simulating lichen planus.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
